Association Between Renal Insufficiency and Lesion Characteristics of Posterior Reversible Encephalopathy Syndrome

Overview

Journal Neurol Sci

Specialty Neurology

Date 2024 Mar 14

PMID 38480646

Authors

Dong Young Jeong

Yea Na Shin

Sang Hee Ha

Jun Young Chang

Dong-Wha Kang

Sun U Kwon

Bum Joon Kim

Affiliations

Soon will be listed here.

Abstract

Background: Posterior reversible encephalopathy syndrome (PRES) is characterized by cerebral blood flow dysregulation and the blood-brain barrier (BBB) disruption. While renal insufficiency has been considered a factor in BBB fragility, the relationship between renal insufficiency and the PRES lesions volume remains unclear.

Methods: This observational study was performed retrospectively. PRES patients were categorized into two groups with renal insufficiency, defined as an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73m on the day of symptom occurrence. Lesion volume was measured using fluid-attenuated inversion recovery (FLAIR) imaging, and the brain was divided into nine regions. The volume of the parietal-occipital-temporal lobe was considered typical, while the other six regions were labeled as atypical.

Results: The study included 200 patients, of whom 94 (47%) had renal insufficiency. Patients with renal insufficiency had a larger lesion volume (144.7 ± 125.2 cc) compared to those without renal insufficiency (110.5 ± 93.2 cc; p = 0.032); particularly in the atypical lesions volume (49.2 ± 65.0 vs. 29.2 ± 44.3 cc; p = 0.013). However, there was no difference in the reversibility of the lesions (35.2 ± 67.5 vs. 18.8 ± 33.4 cc; p = 0.129). Multiple regression analysis revealed that decreases in eGFR (β = -0.34, 95% CI -0.62-0.05, p = 0.020) were positively associated with total lesion volume.

Conclusion: Our findings suggest that PRES patients with renal insufficiency experience more severe lesion volumes, likely due to the atypical brain regions involvement. The lesions involving atypical regions may have a similar pathophysiology to typical lesions, as the PRES lesions reversibility was found to be similar between individuals with and without renal insufficiency.

Citing Articles

A case of posterior and reversible encephalopathy syndrome in a patient previously undiagnosed with lupus nephritis.

Kadoh Y, Yoshino J, Oka T, Itoga K, Hanada M, Niino D CEN Case Rep. 2025; .

PMID: 39918729 DOI: 10.1007/s13730-025-00973-8.

Before blaming metformin as a trigger for stroke-like lesions in MELAS, alternative etiologies must be off the table.

Finsterer J, Mehri S Neurol Sci. 2024; 45(7):3523-3524.

PMID: 38448790 DOI: 10.1007/s10072-024-07444-5.

References

Fugate J, Rabinstein A . Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015; 14(9):914-925. DOI: 10.1016/S1474-4422(15)00111-8. View

Siebert E, Bohner G, Liebig T, Endres M, Liman T . Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study. J Neurol. 2016; 264(2):237-242. DOI: 10.1007/s00415-016-8328-4. View

Gao B, Lyu C, Lerner A, McKinney A . Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?. J Neurol Neurosurg Psychiatry. 2017; 89(1):14-20. DOI: 10.1136/jnnp-2017-316225. View

Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D . Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?. Neuroradiology. 2009; 51(6):373-83. DOI: 10.1007/s00234-009-0504-0. View

Liman T, Bohner G, Endres M, Siebert E . Discharge status and in-hospital mortality in posterior reversible encephalopathy syndrome. Acta Neurol Scand. 2013; 130(1):34-9. DOI: 10.1111/ane.12213. View

Granata G, Greco A, Iannella G, Granata M, Manno A, Savastano E . Posterior reversible encephalopathy syndrome--Insight into pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2015; 14(9):830-6. DOI: 10.1016/j.autrev.2015.05.006. View

Nasu K, Fujisawa M, Kato H, Nangaku M . Three cases of posterior reversible encephalopathy syndrome with chronic kidney disease triggered by infection. Nephrology (Carlton). 2017; 22(4):322-325. DOI: 10.1111/nep.12930. View

Moon S, Jeon S, Choi S, Song C, Chung G, Yu I . Can clinical and MRI findings predict the prognosis of variant and classical type of posterior reversible encephalopathy syndrome (PRES)?. Acta Radiol. 2013; 54(10):1182-90. DOI: 10.1177/0284185113491252. View

Gao B, Liang H, Liu F, Lv C . Isolated pons involvement in posterior reversible encephalopathy syndrome in a patient with chronic renal insufficiency: case report and literature review. Clin Neuroradiol. 2012; 22(4):341-4. DOI: 10.1007/s00062-012-0162-1. View

10.

Casey S, Sampaio R, Michel E, Truwit C . Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol. 2000; 21(7):1199-206. PMC: 8174901. View

11.

Balasa R, Maier S, Baubec E, Bajko Z, Balasa A . Cerebellar and brainstem variant of posterior reversible encephalopathy syndrome. Acta Neurol Belg. 2014; 115(3):401-3. DOI: 10.1007/s13760-014-0370-3. View

12.

Wardlaw J, Smith E, Biessels G, Cordonnier C, Fazekas F, Frayne R . Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013; 12(8):822-38. PMC: 3714437. DOI: 10.1016/S1474-4422(13)70124-8. View

13.

Marrone L, Martins W, Borges M, Rossi B, Brunelli J, Maria Vedana V . Posterior Reversible Encephalopathy Syndrome: Clinical Differences in Patients with Exclusive Involvement of Posterior Circulation Compared to Anterior or Global Involvement. J Stroke Cerebrovasc Dis. 2016; 25(7):1776-1780. DOI: 10.1016/j.jstrokecerebrovasdis.2016.03.042. View

14.

Rabinstein A, Mandrekar J, Merrell R, Kozak O, Durosaro O, Fugate J . Blood pressure fluctuations in posterior reversible encephalopathy syndrome. J Stroke Cerebrovasc Dis. 2011; 21(4):254-8. DOI: 10.1016/j.jstrokecerebrovasdis.2011.03.011. View

15.

Radenkovic M, Stojanovic M, Prostran M . Endothelial Dysfunction in Renal Failure: Current Update. Curr Med Chem. 2016; 23(19):2047-54. DOI: 10.2174/0929867323666151231095126. View

16.

Bai T, Yu S, Feng J . Advances in the Role of Endothelial Cells in Cerebral Small Vessel Disease. Front Neurol. 2022; 13:861714. PMC: 9035937. DOI: 10.3389/fneur.2022.861714. View

17.

Fischer M, Schmutzhard E . Posterior reversible encephalopathy syndrome. J Neurol. 2017; 264(8):1608-1616. PMC: 5533845. DOI: 10.1007/s00415-016-8377-8. View

18.

Pilato F, Distefano M, Calandrelli R . Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Considerations. Front Neurol. 2020; 11:34. PMC: 7033494. DOI: 10.3389/fneur.2020.00034. View

19.

Motolese F, Ferrante M, Rossi M, Magliozzi A, Sbarra M, Ursini F . Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature. J Neurol. 2021; 268(12):4407-4414. PMC: 8294241. DOI: 10.1007/s00415-021-10709-0. View